Last 12 months
Inside the activity.
0 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 12, 2024 Filed Jun 14, 2024 10:13 UTC |
Lindborg StacyDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 112,500 | $0.00 Strike: $1.22 | $0.00 |
DisclosureSEC source: 0001437749-24-020264 · rdgdoc.xml · derivative · entry 1 Lindborg Stacy · CIK 0001813667 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 239,166 Underlying: Common Stock · 112,500 shares Expires 2034-06-12 F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant F2 · derivative.exercise_date: The options vest as follows 1/4 on the one year anniversary of the grant and 1/4 on the second, third and fourth year anniversary Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 10:11 UTC |
Anwer KhursheedChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $1.22 | $0.00 |
DisclosureSEC source: 0001437749-24-020262 · rdgdoc.xml · derivative · entry 1 Anwer Khursheed · CIK 0001611756 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,688 Underlying: Common Stock · 25,000 shares Expires 2034-06-12 F2 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant. F1 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 10:09 UTC |
Fritz Frederick J.Director
|
GrantStock Option (Right to Buy) · Derivative | 3,500 | $0.00 Strike: $1.22 | $0.00 |
DisclosureSEC source: 0001437749-24-020259 · rdgdoc.xml · derivative · entry 1 Fritz Frederick J. · CIK 0001525250 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,099 Underlying: Common Stock · 3,500 shares Expires 2034-06-12 F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 10:08 UTC |
Pellizzari Christine ADirector
|
GrantStock Option (Right to Buy) · Derivative | 4,500 | $0.00 Strike: $1.22 | $0.00 |
DisclosureSEC source: 0001437749-24-020257 · rdgdoc.xml · derivative · entry 1 Pellizzari Christine A · CIK 0001127430 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,666 Underlying: Common Stock · 4,500 shares Expires 2034-06-12 F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 10:06 UTC |
Dentzer James EDirector
|
GrantStock Option (Right to Buy) · Derivative | 4,500 | $0.00 Strike: $1.22 | $0.00 |
DisclosureSEC source: 0001437749-24-020254 · rdgdoc.xml · derivative · entry 1 Dentzer James E · CIK 0001400977 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,667 Underlying: Common Stock · 4,500 shares Expires 2034-06-12 F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 10:05 UTC |
Braun Donald PDirector
|
GrantOption to purchase Imunon common stock · Derivative | 3,500 | $0.00 Strike: $1.22 | $0.00 |
DisclosureSEC source: 0001437749-24-020252 · rdgdoc.xml · derivative · entry 1 Braun Donald P · CIK 0001661392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,430 Underlying: Imunon, Inc. Common Stock · 3,500 shares Expires 2034-06-12 F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant. Read SEC document |
| May 13, 2024 Filed May 14, 2024 20:24 UTC |
Lindborg StacyDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 112,500 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0001437749-24-016643 · rdgdoc.xml · derivative · entry 1 Lindborg Stacy · CIK 0001813667 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,666 Underlying: Common Stock · 112,500 shares Expires 2034-05-13 F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant F2 · derivative.exercise_date: The options vest as follows 1/4 on the one year anniversary of the grant and 1/4 on the second, third and fourth year anniversary Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 21:11 UTC | GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $0.86 | $0.00 |
DisclosureSEC source: 0001437749-24-008350 · rdgdoc.xml · derivative · entry 1 CHURCH JEFFREY WAYNE · CIK 0001240203 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,950 Underlying: Common Stock · 25,000 shares Expires 2034-03-15 F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant. Read SEC document |
|
| March 15, 2024 Filed Mar 18, 2024 21:10 UTC |
Anwer KhursheedChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $0.86 | $0.00 |
DisclosureSEC source: 0001437749-24-008347 · rdgdoc.xml · derivative · entry 1 Anwer Khursheed · CIK 0001611756 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,688 Underlying: Common Stock · 25,000 shares Expires 2034-03-15 F2 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant. F1 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 21:09 UTC |
Tardugno Michael HDirector · Executive Chairman of Board
|
GrantStock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $0.86 | $0.00 |
DisclosureSEC source: 0001437749-24-008345 · rdgdoc.xml · derivative · entry 1 Tardugno Michael H · CIK 0001384550 · Director · Executive Chairman of Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 228,346 Underlying: Common Stock · 12,500 shares Expires 2034-03-15 F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 21:07 UTC |
Fritz Frederick J.Director
|
GrantStock Option (Right to Buy) · Derivative | 3,500 | $0.00 Strike: $0.86 | $0.00 |
DisclosureSEC source: 0001437749-24-008343 · rdgdoc.xml · derivative · entry 1 Fritz Frederick J. · CIK 0001525250 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,599 Underlying: Common Stock · 3,500 shares Expires 2034-03-15 F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 21:07 UTC |
Braun Donald PDirector
|
GrantOption to purchase Imunon common stock · Derivative | 3,500 | $0.00 Strike: $0.86 | $0.00 |
DisclosureSEC source: 0001437749-24-008340 · rdgdoc.xml · derivative · entry 1 Braun Donald P · CIK 0001661392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,930 Underlying: Imunon, Inc. Common Stock · 3,500 shares Expires 2034-03-15 F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 21:05 UTC |
Pellizzari Christine ADirector
|
GrantStock Option (Right to Buy) · Derivative | 4,500 | $0.00 Strike: $0.86 | $0.00 |
DisclosureSEC source: 0001437749-24-008337 · rdgdoc.xml · derivative · entry 1 Pellizzari Christine A · CIK 0001127430 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,166 Underlying: Common Stock · 4,500 shares Expires 2034-03-15 F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 21:04 UTC |
Lindborg StacyDirector
|
GrantStock Option (Right to Buy) · Derivative | 4,500 | $0.00 Strike: $0.86 | $0.00 |
DisclosureSEC source: 0001437749-24-008334 · rdgdoc.xml · derivative · entry 1 Lindborg Stacy · CIK 0001813667 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,166 Underlying: Common Stock · 4,500 shares Expires 2034-03-15 F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second anniversary of the date of grant. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 21:03 UTC |
Dentzer James EDirector
|
GrantStock Option (Right to Buy) · Derivative | 4,500 | $0.00 Strike: $0.86 | $0.00 |
DisclosureSEC source: 0001437749-24-008330 · rdgdoc.xml · derivative · entry 1 Dentzer James E · CIK 0001400977 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,167 Underlying: Common Stock · 4,500 shares Expires 2034-03-15 F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant. Read SEC document |
| March 14, 2024 Filed Mar 18, 2025 20:23 UTC |
Anwer KhursheedChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $0.87 | $0.00 |
DisclosureSEC source: 0001437749-25-008269 · rdgdoc.xml · derivative · entry 1 Anwer Khursheed · CIK 0001611756 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2035-03-14 F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant F2 · derivative.exercise_date: The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant. Read SEC document |
| December 07, 2023 Filed Dec 11, 2023 21:07 UTC |
Hazard SebastienChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $0.88 | $0.00 |
DisclosureSEC source: 0001493152-23-044386 · ownership.xml · derivative · entry 2 Hazard Sebastien · CIK 0002003780 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2033-12-11 F2 · derivative.exercise_date: Represents grant of stock option, which vests with respect to 25% of the shares on December 11, 2024, and the remaining 75% in equal quarterly installments thereafter such that the stock option will be fully vested and exercisable on the fourth anniversary of December 11, 2023. Read SEC document |
| December 07, 2023 Filed Dec 11, 2023 21:07 UTC |
Hazard SebastienChief Medical Officer
|
GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-044386 · ownership.xml · nonDerivative · entry 1 Hazard Sebastien · CIK 0002003780 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 F1 · shares: Represents grant of restricted stock, which vests on December 11, 2024. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 20:42 UTC |
Braun Donald PDirector
|
GrantOption to purchase Imunon common stock · Derivative | 2,000 | $0.00 Strike: $1.32 | $0.00 |
DisclosureSEC source: 0001437749-23-007412 · rdgdoc.xml · derivative · entry 1 Braun Donald P · CIK 0001661392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,430 Underlying: Imunon, Inc. Common Stock · 2,000 shares Expires 2033-03-17 F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/3 on the date of grant; 1/3 on the on the one year anniversary of the date of grant; and 1/3 on the second year anniversary of the date of grant. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 20:41 UTC |
Chow Pok Yu AugustineDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $1.32 | $0.00 |
DisclosureSEC source: 0001437749-23-007411 · rdgdoc.xml · derivative · entry 1 Chow Pok Yu Augustine · CIK 0001392992 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,429 Underlying: Common Stock · 2,000 shares Expires 2033-03-17 F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/3 on the date of grant; 1/3 on the on the one year anniversary of the date of grant; and 1/3 on the second year anniversary of the date of grant. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 20:40 UTC |
Dentzer James EDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $1.32 | $0.00 |
DisclosureSEC source: 0001437749-23-007407 · rdgdoc.xml · derivative · entry 1 Dentzer James E · CIK 0001400977 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,667 Underlying: Common Stock · 2,000 shares Expires 2033-03-17 F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/3 on the date of grant; 1/3 on the on the one year anniversary of the date of grant; and 1/3 on the second year anniversary of the date of grant. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 20:41 UTC |
Fritz Frederick J.Director
|
GrantStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $1.32 | $0.00 |
DisclosureSEC source: 0001437749-23-007410 · rdgdoc.xml · derivative · entry 1 Fritz Frederick J. · CIK 0001525250 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,099 Underlying: Common Stock · 2,000 shares Expires 2033-03-17 F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/3 on the date of grant; 1/3 on the on the one year anniversary of the date of grant; and 1/3 on the second year anniversary of the date of grant. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 20:40 UTC |
Pellizzari Christine ADirector
|
GrantStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $1.32 | $0.00 |
DisclosureSEC source: 0001437749-23-007408 · rdgdoc.xml · derivative · entry 1 Pellizzari Christine A · CIK 0001127430 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,666 Underlying: Common Stock · 2,000 shares Expires 2033-03-17 F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/3 on the date of grant; 1/3 on the on the one year anniversary of the date of grant; and 1/3 on the second year anniversary of the date of grant. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 20:39 UTC |
Lindborg StacyDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $1.32 | $0.00 |
DisclosureSEC source: 0001437749-23-007405 · rdgdoc.xml · derivative · entry 1 Lindborg Stacy · CIK 0001813667 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,666 Underlying: Common Stock · 2,000 shares Expires 2033-03-17 F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/3 on the date of grant; 1/3 on the on the one year anniversary of the date of grant; and 1/3 on the second year anniversary of the date of grant. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 20:38 UTC |
Anwer KhursheedChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $1.32 | $0.00 |
DisclosureSEC source: 0001437749-23-007403 · rdgdoc.xml · derivative · entry 1 Anwer Khursheed · CIK 0001611756 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,688 Underlying: Common Stock · 40,000 shares Expires 2033-03-17 F2 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant. F1 · derivative.exercise_date: The options vest as follows: 1/3 on the date of grant; 1/3 on the on the one year anniversary of the date of grant; and 1/3 on the second year anniversary of the date of grant. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 20:39 UTC |
Tardugno Michael HDirector · Executive Chairman of Board
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $1.32 | $0.00 |
DisclosureSEC source: 0001437749-23-007404 · rdgdoc.xml · derivative · entry 1 Tardugno Michael H · CIK 0001384550 · Director · Executive Chairman of Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 215,846 Underlying: Common Stock · 25,000 shares Expires 2033-03-17 F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/3 on the date of grant; 1/3 on the on the one year anniversary of the date of grant; and 1/3 on the second year anniversary of the date of grant. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 20:37 UTC |
Le Goff CorinneDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 90,000 | $0.00 Strike: $1.32 | $0.00 |
DisclosureSEC source: 0001437749-23-007399 · rdgdoc.xml · derivative · entry 1 Le Goff Corinne · CIK 0001840912 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 320,000 Underlying: Common Stock · 90,000 shares Expires 2033-03-17 F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/3 on the date of grant; 1/3 on the on the one year anniversary of the date of grant; and 1/3 on the second year anniversary of the date of grant. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 20:38 UTC | GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $1.32 | $0.00 |
DisclosureSEC source: 0001437749-23-007402 · rdgdoc.xml · derivative · entry 1 CHURCH JEFFREY WAYNE · CIK 0001240203 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,950 Underlying: Common Stock · 40,000 shares Expires 2033-03-17 F1 · derivative.exercise_price: Represents the closing price of Imunon, Inc. Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/3 on the date of grant; 1/3 on the on the one year anniversary of the date of grant; and 1/3 on the second year anniversary of the date of grant. Read SEC document |
|
| September 30, 2022 Filed Oct 3, 2022 21:19 UTC |
Dentzer James EDirector
|
GrantOption (right to buy) · Derivative | 2,667 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001062993-22-020170 · form4.xml · derivative · entry 1 Dentzer James E · CIK 0001400977 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,667 Underlying: Common Stock · 2,667 shares Expires 2032-09-30 F1 · derivative.exercise_date: Represents an option grant under the Issuer's 2018 Stock Plan. The option vests in equal installments commencing January 1, 2023 and annually thereafter. Read SEC document |
| July 18, 2022 Filed Jul 20, 2022 22:27 UTC |
Le Goff CorinneDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 177,000 | $0.00 Strike: $1.95 | $0.00 |
DisclosureSEC source: 0001062993-22-016571 · form4.xml · derivative · entry 2 Le Goff Corinne · CIK 0001840912 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,000 Underlying: Common Stock · 177,000 shares Expires 2032-07-18 F2 · derivative.exercise_date: Represents grant of stock option which vests with respect to 25% of the shares on July 18, 2023 and the remaining 75% percent in equal quarterly installments thereafter such that the stock option will be fully vested and exercisable on the fourth anniversary of July 18, 2026. Read SEC document |
| July 18, 2022 Filed Jul 20, 2022 22:27 UTC |
Le Goff CorinneDirector · President and CEO
|
GrantCommon Stock | 53,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-016571 · form4.xml · nonDerivative · entry 1 Le Goff Corinne · CIK 0001840912 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,000 F1 · shares: Represents grant of restricted stock which vests on July 18, 2023. Read SEC document |
| June 13, 2022 Filed Jun 15, 2022 20:50 UTC |
Fritz Frederick J.Director
|
GrantOption to Purchase Celsion Common Stock · Derivative | 7,500 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001437749-22-015072 · rdgdoc.xml · derivative · entry 1 Fritz Frederick J. · CIK 0001525250 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,004 Underlying: Celsion Corporation Common Stock · 7,500 shares Expires 2032-06-13 F1 · derivative.exercise_price: Represents the per share fair value of the Common Stock based on the closing price of a share of Celsion Corporation Common Stock on the date of the grant. F2 · derivative.exercise_date: The Options vest as follows: 1/3 on the date of the grant, 1/3 on the one year anniversary of the date of the grant, and 1/3 on the second year anniversary of the date of the grant. Read SEC document |
| June 13, 2022 Filed Jun 15, 2022 20:55 UTC |
Kardaras Constantine JohnChief Accounting Officer
|
GrantOption to Purchase Celsion Common Stock · Derivative | 1,750 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001437749-22-015078 · rdgdoc.xml · derivative · entry 1 Kardaras Constantine John · CIK 0001899660 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,833 Underlying: Celsion Corporation Common Stock · 1,750 shares Expires 2032-06-13 F1 · derivative.exercise_price: Represents the per share fair value of the Common Stock based on the closing price of a share of Celsion Corporation Common Stock on the date of the grant. F2 · derivative.exercise_date: The Options vest as follows: 1/3 on the date of the grant, 1/3 on the one year anniversary of the date of the grant, and 1/3 on the second year anniversary of the date of the grant. Read SEC document |
| June 13, 2022 Filed Jun 15, 2022 20:53 UTC |
Tumminello Timothy JController
|
GrantOption to Purchase Celsion Common Stock · Derivative | 7,500 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001437749-22-015076 · rdgdoc.xml · derivative · entry 1 Tumminello Timothy J · CIK 0001480334 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,300 Underlying: Celsion Corporation Common Stock · 7,500 shares Expires 2032-06-13 F1 · derivative.exercise_price: Represents the per share fair value of the Common Stock based on the closing price of a share of Celsion Corporation Common Stock on the date of the grant. F2 · derivative.exercise_date: The Options vest as follows: 1/3 on the date of the grant, 1/3 on the one year anniversary of the date of the grant, and 1/3 on the second year anniversary of the date of the grant. Read SEC document |
| June 13, 2022 Filed Jun 15, 2022 20:52 UTC |
Chow Pok Yu AugustineDirector
|
GrantOption to Purchase Celsion Common Stock · Derivative | 7,500 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001437749-22-015074 · rdgdoc.xml · derivative · entry 1 Chow Pok Yu Augustine · CIK 0001392992 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,242 Underlying: Celsion Corporation Common Stock · 7,500 shares Expires 2032-06-13 F1 · derivative.exercise_price: Represents the per share fair value of the Common Stock based on the closing price of a share of Celsion Corporation Common Stock on the date of the grant. F2 · derivative.exercise_date: The Options vest as follows: 1/3 on the date of the grant, 1/3 on the one year anniversary of the date of the grant, and 1/3 on the second year anniversary of the date of the grant. Read SEC document |
| June 13, 2022 Filed Jun 15, 2022 20:49 UTC |
Hooper Robert WDirector
|
GrantOption to Purchase Celsion Common Stock · Derivative | 7,500 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001437749-22-015070 · rdgdoc.xml · derivative · entry 1 Hooper Robert W · CIK 0001497872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,978 Underlying: Celsion Corporation Common Stock · 7,500 shares Expires 2032-06-13 F1 · derivative.exercise_price: Represents the per share fair value of the Common Stock based on the closing price of a share of Celsion Corporation Common Stock on the date of the grant. F2 · derivative.exercise_date: The Options vest as follows: 1/3 on the date of the grant, 1/3 on the one year anniversary of the date of the grant, and 1/3 on the second year anniversary of the date of the grant. Read SEC document |
| June 13, 2022 Filed Jun 15, 2022 20:47 UTC |
Lindborg StacyDirector
|
GrantOption to Purchase Celsion Common Stock · Derivative | 2,500 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001437749-22-015068 · rdgdoc.xml · derivative · entry 1 Lindborg Stacy · CIK 0001813667 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,666 Underlying: Celsion Corporation Common Stock · 2,500 shares Expires 2032-06-13 F1 · derivative.exercise_price: Represents the per share fair value of the Common Stock based on the closing price of a share of Celsion Corporation Common Stock on the date of the grant. F2 · derivative.exercise_date: The Options vest as follows: 1/3 on the date of the grant, 1/3 on the one year anniversary of the date of the grant, and 1/3 on the second year anniversary of the date of the grant. Read SEC document |
| June 13, 2022 Filed Jun 15, 2022 20:44 UTC |
Pellizzari Christine ADirector
|
GrantOption to Purchase Celsion Common Stock · Derivative | 2,500 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001437749-22-015065 · rdgdoc.xml · derivative · entry 1 Pellizzari Christine A · CIK 0001127430 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,666 Underlying: Celsion Corporation Common Stock · 2,500 shares Expires 2032-06-13 F1 · derivative.exercise_price: Represents the per share fair value of the Common Stock based on the closing price of a share of Celsion Corporation Common Stock on the date of the grant. F2 · derivative.exercise_date: The Options vest as follows: 1/3 on the date of the grant, 1/3 on the one year anniversary of the date of the grant, and 1/3 on the second year anniversary of the date of the grant. Read SEC document |
| June 13, 2022 Filed Jun 15, 2022 20:39 UTC |
Braun Donald PDirector
|
GrantOption to Purchase Celsion Common Stock · Derivative | 6,250 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001437749-22-015061 · rdgdoc.xml · derivative · entry 1 Braun Donald P · CIK 0001661392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,587 Underlying: Celsion Corporation Common Stock · 6,250 shares Expires 2032-06-13 F1 · derivative.exercise_price: Represents the per share fair value of the Common Stock based on the closing price of a share of Celsion Corporation Common Stock on the date of the grant. F2 · derivative.exercise_date: The Options vest as follows: 1/3 on the date of the grant, 1/3 on the one year anniversary of the date of the grant, and 1/3 on the second year anniversary of the date of the grant. Read SEC document |
| June 13, 2022 Filed Jun 15, 2022 20:36 UTC | GrantOption to Purchase Celsion Common Stock · Derivative | 50,000 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001437749-22-015059 · rdgdoc.xml · derivative · entry 1 CHURCH JEFFREY WAYNE · CIK 0001240203 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,659 Underlying: Celsion Corporation Common Stock · 50,000 shares Expires 2032-06-13 F1 · derivative.exercise_price: Represents the per share fair value of the Common Stock based on the closing price of a share of Celsion Corporation Common Stock on the date of the grant. F2 · derivative.exercise_date: The Options vest as follows: 1/3 on the date of the grant, 1/3 on the one year anniversary of the date of the grant, and 1/3 on the second year anniversary of the date of the grant. Read SEC document |
|
| June 13, 2022 Filed Jun 15, 2022 20:32 UTC |
Tardugno Michael HDirector · Chairman, President and CEO
|
GrantOption to Purchase Celsion Common Stock · Derivative | 90,000 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001437749-22-015057 · rdgdoc.xml · derivative · entry 1 Tardugno Michael H · CIK 0001384550 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 303,068 Underlying: Celsion Corporation Common Stock · 90,000 shares Expires 2032-06-13 F1 · derivative.exercise_price: Represents the per share fair value of the Common Stock based on the closing price of a share of Celsion Corporation Common Stock on the date of the grant. F2 · derivative.exercise_date: The Options vest as follows: 1/3 on the date of the grant, 1/3 on the one year anniversary of the date of the grant, and 1/3 on the second year anniversary of the date of the grant. Read SEC document |
| April 12, 2022 Filed Apr 12, 2022 18:19 UTC |
Tardugno Michael HDirector · Chairman, President and CEO
|
PurchaseCelsion Corporation Common Stock | 4,000 | $3.53 | $14,129.20 |
DisclosureSEC source: 0001437749-22-008740 · rdgdoc.xml · nonDerivative · entry 1 Tardugno Michael H · CIK 0001384550 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,513 F1 · shares: The shares were purchased on the open market. Read SEC document |
| April 08, 2022 Filed Apr 11, 2022 19:09 UTC |
Fritz Frederick J.Director
|
PurchaseCelsion Corporation Common Stock | 5,000 | $4.05 | $20,250.00 |
DisclosureSEC source: 0001437749-22-008664 · rdgdoc.xml · nonDerivative · entry 1 Fritz Frederick J. · CIK 0001525250 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,766 F1 · shares: The shares were purchased on the open market. Read SEC document |
| March 04, 2022 Filed Mar 7, 2022 23:07 UTC |
Kardaras Constantine JohnChief Accounting Officer
|
GrantOption to Purchase Celsion Common Stock · Derivative | 1,750 | $0.00 Strike: $4.60 | $0.00 |
DisclosureSEC source: 0001437749-22-005440 · rdgdoc.xml · derivative · entry 1 Kardaras Constantine John · CIK 0001899660 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,083 Underlying: Celsion Corporation Common Stock · 1,750 shares Expires 2032-03-04 F1 · derivative.exercise_price: Represents the per share fair value of the Common Stock based on the closing price of a share of Celsion Corporation Common Stock on the date of the grant. F2 · derivative.exercise_date: The Options vest as follows: 1/3 on the date of the grant, 1/3 on the one year anniversary of the date of the grant, and 1/3 on the second year anniversary of the date of the grant. Read SEC document |
| March 04, 2022 Filed Mar 7, 2022 23:08 UTC |
Tumminello Timothy JController
|
GrantOption to Purchase Celsion Common Stock · Derivative | 7,500 | $0.00 Strike: $4.60 | $0.00 |
DisclosureSEC source: 0001437749-22-005442 · rdgdoc.xml · derivative · entry 1 Tumminello Timothy J · CIK 0001480334 · Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,800 Underlying: Celsion Corporation Common Stock · 7,500 shares Expires 2032-03-04 F1 · security: Represents the per share fair value of the Common Stock based on the closing price of a share of Celsion Corporation Common Stock on the date of the grant. F2 · derivative.exercise_date: The Options vest as follows: 1/3 on the date of the grant, 1/3 on the one year anniversary of the date of the grant, and 1/3 on the second year anniversary of the date of the grant. Read SEC document |
| March 04, 2022 Filed Mar 7, 2022 23:06 UTC |
Tardugno Michael HDirector · Chairman, President and CEO
|
GrantOption to Purchase Celsion Common Stock · Derivative | 80,000 | $0.00 Strike: $4.60 | $0.00 |
DisclosureSEC source: 0001437749-22-005439 · rdgdoc.xml · derivative · entry 1 Tardugno Michael H · CIK 0001384550 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,068 Underlying: Celsion Corporation Common Stock · 80,000 shares Expires 2032-03-04 F1 · derivative.exercise_price: Represents the per share fair value of the Common Stock based on the closing price of a share of Celsion Corporation Common Stock on the date of the grant. F2 · derivative.exercise_date: The Options vest as follows: 1/3 on the date of the grant, 1/3 on the one year anniversary of the date of the grant, and 1/3 on the second year anniversary of the date of the grant. Read SEC document |
| March 04, 2022 Filed Mar 7, 2022 23:04 UTC |
Braun Donald PDirector
|
GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 6,250 | $0.00 Strike: $4.60 | $0.00 |
DisclosureSEC source: 0001437749-22-005436 · rdgdoc.xml · derivative · entry 1 Braun Donald P · CIK 0001661392 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,337 Underlying: Celsion Corporation Common Stock · 6,250 shares Expires 2032-03-04 Read SEC document |
| March 04, 2022 Filed Mar 7, 2022 23:01 UTC |
Lindborg StacyDirector
|
GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 2,500 | $0.00 Strike: $4.60 | $0.00 |
DisclosureSEC source: 0001437749-22-005432 · rdgdoc.xml · derivative · entry 1 Lindborg Stacy · CIK 0001813667 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,166 Underlying: Celsion Corporation Common Stock · 2,500 shares Expires 2032-03-04 F1 · derivative.exercise_price: Represents the per share per share fair value of the common stock based on the closing price of a share of Celsion Stock on the date of the award. F2 · derivative.exercise_date: The options vest as follows: 1/3 on the date of grant; 1/3 on the one year anniversary of the date of grant; and 1/3 on the second year anniversary of the date of grant. Read SEC document |
| March 04, 2022 Filed Mar 7, 2022 22:58 UTC |
Pellizzari Christine ADirector
|
GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 2,500 | $0.00 Strike: $4.60 | $0.00 |
DisclosureSEC source: 0001437749-22-005429 · rdgdoc.xml · derivative · entry 1 Pellizzari Christine A · CIK 0001127430 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,166 Underlying: Celsion Corporation Common Stock · 2,500 shares Expires 2032-03-04 F1 · derivative.exercise_price: Represents the per share value of the Common Stock on the closing price of a share of Celsion Corporation Common Stock on the date of grant. F2 · derivative.exercise_date: The options vest as follows: 1/3 on the date of grant; 1/3 on the one year anniversary of the date of grant; and 1/3 on the second year anniversary of the date of grant. Read SEC document |
| March 04, 2022 Filed Mar 7, 2022 22:52 UTC |
Hooper Robert WDirector
|
GrantOption to Purchase Celsion Corporation Common Stock · Derivative | 7,500 | $0.00 Strike: $4.60 | $0.00 |
DisclosureSEC source: 0001437749-22-005420 · rdgdoc.xml · derivative · entry 1 Hooper Robert W · CIK 0001497872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,478 Underlying: Celsion Corporation Common Stock · 7,500 shares Expires 2032-03-04 F2 · derivative.exercise_price: Represents the per share value of the Common Stock on the closing price of a share of Celsion Corporation Common Stock on the date of grant. F1 · derivative.exercise_date: The options vest as follows: 1/3 on the date of grant; 1/3 on the on the one year anniversary of the date of grant; and 1/3 on the second year anniversary of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.